Dr. Baffy received his MD from the University of Debrecen. He trained in gastroenterology at the University of Michigan and the Brigham and Women’s Hospital. He is currently chief of gastroenterology at the VA Boston Healthcare System and associate professor at Harvard Medical School. His research focuses on metabolic dysfunction-associated steatotic liver disease (MASLD), including early portal hypertension and liver mechanobiology. He is involved in several multicenter studies addressing palliative care in end-stage liver disease, use of simvastatin in near-decompensated cirrhosis, and HCC surveillance. He published over 120 peer-reviewed papers and book chapters. He has been a member of various scientific review panels and journal editorial boards in the field. He was a Fulbright US Scholar in 2014. He is the recipient of the Madaus Prize from the Madaus Liver Foundation and the Hetényi Medal and Pro Optimo Merito in Gastroenterologia Award from the Hungarian Gastroenterological Association.